McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. February 5, 2026 – Often in the policy realm (and especially in the health space), major reforms are ...
Transparency mandates require detailed disclosure of rebates, spread pricing, fees, and reimbursement methodologies, expanding plan sponsor audit rights and increasing CMS oversight of PBM reporting ...
Pharmacy Benefit Managers (PBMs) play a large role in deciding which drugs patients receive and how much they pay. Yet their fees, rebates, and contracts remain largely hidden from employers, insurers ...
Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack competitive conditions. Learnings from transparency will shape future drug pricing ...
Omnibus Funding Bill. On February 3, 2026, Congress enacted an omnibus funding bill that, among other provisions, mandates delinking PBM compensation from list prices in Medicare Part D; requires flat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results